Supraclavicular Brachial Plexus Block as Opioid Sparing Technique in Pediatrics Undergoing Arteriovenous Fistula Creation

Launched by TANTA UNIVERSITY · May 31, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at a method called supraclavicular brachial plexus block to help reduce the need for opioids in children who are having a specific surgery called arteriovenous fistula creation. This surgery is often needed for patients who require dialysis, and the goal of the study is to see if this technique can provide effective pain relief while using fewer strong pain medications like opioids.

To participate in this trial, children between the ages of 6 and 18 who are in good health (as defined by a specific medical rating) and are scheduled for this surgery under general anesthesia may be eligible. However, children with allergies to local anesthetics, infections at the surgery site, or certain medical conditions won't be able to join. If your child is selected, they can expect to receive the supraclavicular block as part of their pain management during the surgery, which could help them feel more comfortable while reducing the potential side effects of opioids.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age from 6 to 18 years.
• • Both sexes.
• • American Society of Anesthesiology (ASA) physical status I- III.
• • Undergoing arteriovenous fistula creation under general anesthesia.
• Exclusion Criteria:
• • Allergy to local anesthetics.
• • Infection at the site of block.
• • Local infection.
• • Coagulation disorder.
• • Previously failed or revision of blocked arteriovenous fistula.